vs

Side-by-side financial comparison of Teradyne (TER) and VEON Ltd. (VEON). Click either name above to swap in a different company.

Teradyne is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× VEON Ltd.). VEON Ltd. runs the higher net margin — 55.9% vs 31.1%, a 24.8% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 5.8%).

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

VEON Ltd., also known as VEON Group, is a multinational telecommunication and digital services company. Headquartered in Dubai, the company is publicly traded on the U.S.-based NASDAQ stock exchange. VEON operates in six markets in Europe and Asia, including Bangladesh, Kazakhstan, Kyrgyzstan, Pakistan, Ukraine and Uzbekistan. Specific brands include Banglalink in Bangladesh, Jazz in Pakistan, Kyivstar in Ukraine, and units operating in Kazakhstan, Kyrgyzstan, and Uzbekistan under the Beeline...

TER vs VEON — Head-to-Head

Bigger by revenue
TER
TER
1.2× larger
TER
$1.3B
$1.1B
VEON
Growing faster (revenue YoY)
TER
TER
+81.2% gap
TER
87.0%
5.8%
VEON
Higher net margin
VEON
VEON
24.8% more per $
VEON
55.9%
31.1%
TER

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
TER
TER
VEON
VEON
Revenue
$1.3B
$1.1B
Net Profit
$398.9M
$608.0M
Gross Margin
60.9%
Operating Margin
36.9%
75.4%
Net Margin
31.1%
55.9%
Revenue YoY
87.0%
5.8%
Net Profit YoY
583.1%
EPS (diluted)
$2.53
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TER
TER
VEON
VEON
Q1 26
$1.3B
Q4 25
$1.1B
Q3 25
$769.2M
Q2 25
$651.8M
$1.1B
Q1 25
$685.7M
Q4 24
$752.9M
Q3 24
$737.3M
Q2 24
$729.9M
$1.0B
Net Profit
TER
TER
VEON
VEON
Q1 26
$398.9M
Q4 25
$257.2M
Q3 25
$119.6M
Q2 25
$78.4M
$608.0M
Q1 25
$98.9M
Q4 24
$146.3M
Q3 24
$145.6M
Q2 24
$186.3M
$89.0M
Gross Margin
TER
TER
VEON
VEON
Q1 26
60.9%
Q4 25
57.2%
Q3 25
58.4%
Q2 25
57.2%
Q1 25
60.6%
Q4 24
59.4%
Q3 24
59.2%
Q2 24
58.3%
Operating Margin
TER
TER
VEON
VEON
Q1 26
36.9%
Q4 25
27.1%
Q3 25
18.9%
Q2 25
13.9%
75.4%
Q1 25
17.6%
Q4 24
20.4%
Q3 24
20.6%
Q2 24
28.8%
27.1%
Net Margin
TER
TER
VEON
VEON
Q1 26
31.1%
Q4 25
23.7%
Q3 25
15.5%
Q2 25
12.0%
55.9%
Q1 25
14.4%
Q4 24
19.4%
Q3 24
19.8%
Q2 24
25.5%
8.7%
EPS (diluted)
TER
TER
VEON
VEON
Q1 26
$2.53
Q4 25
$1.62
Q3 25
$0.75
Q2 25
$0.49
$0.34
Q1 25
$0.61
Q4 24
$0.89
Q3 24
$0.89
Q2 24
$1.14
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TER
TER
VEON
VEON
Cash + ST InvestmentsLiquidity on hand
$241.9M
$1.3B
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$1.5B
Total Assets
$4.4B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TER
TER
VEON
VEON
Q1 26
$241.9M
Q4 25
$293.8M
Q3 25
$272.7M
Q2 25
$339.3M
$1.3B
Q1 25
$475.6M
Q4 24
$553.4M
Q3 24
$510.0M
Q2 24
$421.9M
$862.0M
Total Debt
TER
TER
VEON
VEON
Q1 26
$0
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
TER
TER
VEON
VEON
Q1 26
Q4 25
$2.8B
Q3 25
$2.7B
Q2 25
$2.8B
$1.5B
Q1 25
$2.8B
Q4 24
$2.8B
Q3 24
$2.9B
Q2 24
$2.7B
$1.1B
Total Assets
TER
TER
VEON
VEON
Q1 26
$4.4B
Q4 25
$4.2B
Q3 25
$4.0B
Q2 25
$3.8B
$8.5B
Q1 25
$3.7B
Q4 24
$3.7B
Q3 24
$3.8B
Q2 24
$3.6B
$7.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TER
TER
VEON
VEON
Operating Cash FlowLast quarter
$265.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TER
TER
VEON
VEON
Q1 26
$265.1M
Q4 25
$281.6M
Q3 25
$49.0M
Q2 25
$182.1M
Q1 25
$161.6M
Q4 24
$282.6M
Q3 24
$166.3M
Q2 24
$216.1M
Free Cash Flow
TER
TER
VEON
VEON
Q1 26
Q4 25
$218.8M
Q3 25
$2.4M
Q2 25
$131.7M
Q1 25
$97.6M
Q4 24
$225.2M
Q3 24
$114.4M
Q2 24
$171.2M
FCF Margin
TER
TER
VEON
VEON
Q1 26
Q4 25
20.2%
Q3 25
0.3%
Q2 25
20.2%
Q1 25
14.2%
Q4 24
29.9%
Q3 24
15.5%
Q2 24
23.5%
Capex Intensity
TER
TER
VEON
VEON
Q1 26
Q4 25
5.8%
Q3 25
6.1%
Q2 25
7.7%
Q1 25
9.3%
Q4 24
7.6%
Q3 24
7.0%
Q2 24
6.1%
Cash Conversion
TER
TER
VEON
VEON
Q1 26
0.66×
Q4 25
1.09×
Q3 25
0.41×
Q2 25
2.32×
Q1 25
1.63×
Q4 24
1.93×
Q3 24
1.14×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons